9I制作厂免费

Professor Larry Lynd is a pharmacist, epidemiologist, and health outcomes researcher. He completed his PhD in the Department of Health Care and Epidemiology at UBC and his post-doctoral fellowship in health economics at McMaster University. Currently, Professor Lynd is Professor at the UBC Faculty of Pharmaceutical Sciences; at the Centre for Health Evaluation and Outcomes Sciences at the Providence Health Research Institute; Scholar at the Peter Wall Institute of Advanced Studies; and Associate of the UBC School of Population and Public Health.

Prof. Lynd鈥檚 research focuses on the integration of epidemiologic and health economic analyses on health outcomes, including the use of large administrative health datasets, to inform practice, policy, and research. His primary areas of research include the testing and treatment of rare diseases, multiple sclerosis, and respiratory disease. He is the lead of the epidemiology/health economics themes for the: CANadian PROactive Cohort study for People Living with MS, a 5-year pan-Canadian prospective cohort study in multiple sclerosis; the GenCOUNSEL study, evaluating the implementation of whole genome sequencing for the provision of clinical genetic services; and, the Early Health Technology Assessment platform for the Nanomedicines Innovation Network.

Prof. Lynd has made significant contributions serving on a number of committees, including chair of the Health Canada Special Advisory Committee on Non-Prescription Drugs, Special Advisory Committee to the Respiratory and Allergy Therapies Division of Health Canada, BC Ministry of Health Services Expensive Drugs for Rare Diseases Committee, and the BC PharmaNet Data Stewardship Committee.